Skip to content

Clinical trials

Terminated Urogenital Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Status: Terminated Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20102
20113
20132
20141
20154
20171
20182
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celldex Therapeutics3
Duke University2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Advanced Accelerator Applications1
Alessandro D'Agnolo1
Bioniche Life Sciences Inc.1
Cedars-Sinai Medical Center1
Endo USA Inc., a Keenova Therapeutics Company1
Lantheus Biosciences Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms21
Neoplasms9
Prostatic Neoplasms9
Neoplasms by Site8
Genital Neoplasms, Male7
Urinary Bladder Neoplasms6
Urologic Diseases5
Urologic Neoplasms5
Carcinoma, Renal Cell4
Kidney Neoplasms4

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.